Letter: Ill, or just shy?
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Sir: Your leader "Who should pay for the `lifestyle' pills?" (9 October) is a simplistic and misguided view of the use of the antidepressant Seroxat. The way that drug works is far more sophisticated than the instant buzz of alcohol and cannabis and the condition it treats is more complex than the term "shyness" suggests. A lack of confidence can be the result of a clinical mental illness as well as inexperience or personality.
I write not as a boffin but as a user and I disagree that the drug is not cost-effective. For nine years, since graduating in engineering, I was unable to get a job of any description. After taking Seroxat for two years I have now had a job for seven months and my life has improved. It may be that the pharmaceutical companies overcharge for drugs but in this case the state wins and the user wins.
Name and address supplied
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments